565 related articles for article (PubMed ID: 21947790)
1. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
2. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
3. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
4. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.
Schöttker B; Müller H; Rothenbacher D; Brenner H
Diabetologia; 2013 Jan; 56(1):92-100. PubMed ID: 22986731
[TBL] [Abstract][Full Text] [Related]
5. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
Kharroubi AT; Darwish HM; Abu Al-Halaweh AI; Khammash UM
PLoS One; 2014; 9(2):e88123. PubMed ID: 24505401
[TBL] [Abstract][Full Text] [Related]
7. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
8. Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).
Heianza Y; Arase Y; Hsieh SD; Saito K; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
Diabetologia; 2012 Dec; 55(12):3213-23. PubMed ID: 22955996
[TBL] [Abstract][Full Text] [Related]
9. HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).
Valdés S; Botas P; Delgado E; Alvarez F; Díaz-Cadórniga F
Diabetes Metab; 2011 Feb; 37(1):27-32. PubMed ID: 20934897
[TBL] [Abstract][Full Text] [Related]
10. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
11. Use of high-normal levels of haemoglobin A(1C) and fasting plasma glucose for diabetes screening and for prediction: a meta-analysis.
Kodama S; Horikawa C; Fujihara K; Hirasawa R; Yachi Y; Yoshizawa S; Tanaka S; Sone Y; Shimano H; Iida KT; Saito K; Sone H
Diabetes Metab Res Rev; 2013 Nov; 29(8):680-92. PubMed ID: 23963843
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
Kim KS; Kim SK; Lee YK; Park SW; Cho YW
Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
[TBL] [Abstract][Full Text] [Related]
13. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
14. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
15. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
16. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
[TBL] [Abstract][Full Text] [Related]
17. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus.
Tekumit H; Cenal AR; Polat A; Uzun K; Tataroglu C; Akinci E
Ann Thorac Surg; 2010 May; 89(5):1482-7. PubMed ID: 20417764
[TBL] [Abstract][Full Text] [Related]
19. Effect of HbA1c combined FPG on screening diabetes in health check-up.
Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
[TBL] [Abstract][Full Text] [Related]
20. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
Nair M; Prabhakaran D; Narayan KM; Sinha R; Lakshmy R; Devasenapathy N; Daniel CR; Gupta R; George PS; Mathew A; Tandon N; Reddy KS
Prim Care Diabetes; 2011 Jul; 5(2):95-102. PubMed ID: 21474403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]